Literature DB >> 11001923

Interaction between LIS1 and doublecortin, two lissencephaly gene products.

M Caspi1, R Atlas, A Kantor, T Sapir, O Reiner.   

Abstract

Mutations in either LIS1 or DCX are the most common cause for type I lissencephaly. Here we report that LIS1 and DCX interact physically both in vitro and in vivo. Epitope-tagged DCX transiently expressed in COS cells can be co-immunoprecipitated with endogenous LIS1. Furthermore, endogenous DCX could be co-immunoprecipitated with endogenous LIS1 in embryonic brain extracts, demonstrating an in vivo association. The two protein products also co-localize in transfected cells and in primary neuronal cells. In addition, we demonstrate homodimerization of DCX in vitro. Using fragments of both LIS1 and DCX, the domains of interaction were mapped. LIS1 and DCX interact with tubulin and microtubules. Our results suggest that addition of DCX and LIS1 to tubulin enhances polymerization in an additive fashion. In in vitro competition assays, when LIS1 is added first, DCX competes with LIS1 in its binding to microtubules, but when DCX is added prior to the addition of LIS1 it enhances the binding of LIS1 to microtubules. We conclude that LIS1 and DCX cross-talk is important to microtubule function in the developing cerebral cortex.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11001923     DOI: 10.1093/oxfordjournals.hmg.a018911

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  46 in total

1.  LIS1, CLIP-170's key to the dynein/dynactin pathway.

Authors:  Frédéric M Coquelle; Michal Caspi; Fabrice P Cordelières; Jim P Dompierre; Denis L Dujardin; Cynthia Koifman; Patrick Martin; Casper C Hoogenraad; Anna Akhmanova; Niels Galjart; Jan R De Mey; Orly Reiner
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

2.  Reelin' in Genes for Cortical Dysplasia.

Authors:  Peter B. Crino
Journal:  Epilepsy Curr       Date:  2001-11       Impact factor: 7.500

3.  Doublecortin (DCX) mediates endocytosis of neurofascin independently of microtubule binding.

Authors:  Chan Choo Yap; Max Vakulenko; Kamil Kruczek; Bashir Motamedi; Laura Digilio; Judy S Liu; Bettina Winckler
Journal:  J Neurosci       Date:  2012-05-30       Impact factor: 6.167

Review 4.  Polarity regulation in migrating neurons in the cortex.

Authors:  Orly Reiner; Tamar Sapir
Journal:  Mol Neurobiol       Date:  2009-03-28       Impact factor: 5.590

Review 5.  Integrative mechanisms of oriented neuronal migration in the developing brain.

Authors:  Irina Evsyukova; Charlotte Plestant; E S Anton
Journal:  Annu Rev Cell Dev Biol       Date:  2013-08-07       Impact factor: 13.827

6.  Novel embryonic neuronal migration and proliferation defects in Dcx mutant mice are exacerbated by Lis1 reduction.

Authors:  Tiziano Pramparo; Yong Ha Youn; Jessica Yingling; Shinji Hirotsune; Anthony Wynshaw-Boris
Journal:  J Neurosci       Date:  2010-02-24       Impact factor: 6.167

7.  Interkinetic nuclear movement in the ventricular zone of the cortex.

Authors:  Orly Reiner; Tamar Sapir; Gabi Gerlitz
Journal:  J Mol Neurosci       Date:  2011-09-01       Impact factor: 3.444

Review 8.  Cytoskeleton in action: lissencephaly, a neuronal migration disorder.

Authors:  Hyang Mi Moon; Anthony Wynshaw-Boris
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2013 Mar-Apr       Impact factor: 5.814

9.  A new activity of doublecortin in recognition of the phospho-FIGQY tyrosine in the cytoplasmic domain of neurofascin.

Authors:  Krishnakumar Kizhatil; Yi-Xin Wu; Anindita Sen; Vann Bennett
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

10.  The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes.

Authors:  Jerzy Wegiel; Izabela Kuchna; Krzysztof Nowicki; Humi Imaki; Jarek Wegiel; Elaine Marchi; Shuang Yong Ma; Abha Chauhan; Ved Chauhan; Teresa Wierzba Bobrowicz; Mony de Leon; Leslie A Saint Louis; Ira L Cohen; Eric London; W Ted Brown; Thomas Wisniewski
Journal:  Acta Neuropathol       Date:  2010-03-03       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.